Yeji
NDA/BLA filedconf 0.70

reproxalap — NDA/BLA filed

$ALDX · Aldeyra Therapeutics, Inc. · dry eye disease
Event date
Date TBD
Sponsor runway
38 mo
$65.0M liquid

Evidence

“received minutes (the Minutes) from a Type A meeting, held on June 10, 2026 with the U.S. Food and Drug Administration (FDA), regarding potential resubmission of the New Drug Application (NDA) of reproxalap for the treatment of dry eye disease”
Source: 8-K filed 2026-07-15View on EDGAR ↗0001193125-26-304880

Comparable historical nda/bla fileds· last 5 years · same indication

TickerDrugDateOutcome
$ALDXreproxalap2025-07-17unknown
$ALDXreproxalap2024-11-01unknown
$ALDXreproxalap2023-02-07unknown
$ALDXreproxalap2023-02-01unknown

Recent insider activity· ±90 days

No insider Form 4 activity reported on $ALDX in the 90 days around this event.
← All catalysts for $ALDX